Skip to content
MARKETS / BALCAO / RMSL
BALCAO · SERVICES-PERSONAL SERVICES · SMALL CAP

RemSleep Holdings Inc. RMSL

16 fiscal years on record · USD · FY2025 reported · SEC filings only
$16,721
▼ 85.7% YoY
$-3.0M
In brief

What this company does

Our patented DeltaWave product is a nasal-pillows type interface that will result in better comfort and, therefore, better compliance since it was specifically designed with unique airflow characteristics to enable patients with sleep apnea to breathe normally. On April 27, 2021, REMSleep was awarded utility patent 10987481 for its new Deltawave CPAP Pillows Mask for delivery of CPAP therapy and other respiratory needs. Our goal is to continue to develop sleep products for the treatment of OSA and capture 10% of the market in the next 12 months.

Written from the business description in Remsleep Holdings, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 15 April 2026. Every sentence was checked against that document before publication.

Growth
USD 16,721.00
Revenue, FY2025 · full 16-year series below
Revenue $M Net income $M
FY2025 · Revenue 0.0 · Net income -3.0
-2M201020122014201620182020202220242025
Compound annual growth
−62.6%
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−18063 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -16552.7% · Net -18062.9%
-5000%-10000%-15000%201020122014201620182020202220242025
ROE
FY2025 · ROE -1638.1%
-500000%-1000000%201020122014201620182020202220242025

Each USD of equity lost 1638 cents this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2024 · FCF -0.8
-0.8M-1.6M201020122014201620182020202220242025

Total assetsUSD 339,756.00
EquityUSD 32,062.00
CashUSD 214,514.00
Current ratio0.89×

Equity funds 9% of total assets.

The 16-year record
16 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 2025202420232022202120202019201820172016201520142013201220112010
Revenue $B0.00.00.00.0·······0.00.0···
Operating income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EBITDA $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0····
Income tax $B········0.00.0·0.00.0···
Net income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.1
Free cash flow $B·−0.0−0.0−0.0−0.0−0.0−0.0−0.0·−0.0−0.0−0.0····
EPS, diluted $0.000.000.000.00−0.01−0.01−0.09−0.10−0.19−0.060.000.00−16.05−0.05−0.11−1.36
Dividend / sh $················
Payout %················
ROE %−1638.1−170.1−97.7−55.8−437.7·········−165039.6−1062159.9
Shares out B1.661.521.461.461.230.370.120.000.000.000.060.060.000.340.300.30

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 63 reconciliationsAUDITED

Reconciled in 16 of 19 fiscal years. 32 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-Personal Services
Listed onOTC market
Incorporated inNevada
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2010

Share this section

Download image